Stock comparison
Medline Inc. is 28.3x more valuable than AtriCure, Inc. by market capitalization ($49.12 B vs $1.74 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MDLN is larger
Medline Inc. is 28.3x more valuable than AtriCure, Inc. by market capitalization ($49.12 B vs $1.74 B).
Market value leader
MDLN
Medline Inc. is 28.3x more valuable than AtriCure, Inc. by market capitalization ($49.12 B vs $1.74 B).
Revenue leader
MDLN
ATRC: $534.53M vs MDLN: $28.43B.
Profit leader
MDLN
ATRC: -$11.45M vs MDLN: $1.16T.
Margin leader
MDLN
ATRC: -2.1% vs MDLN: 4069.4% net margin.
| Metric | ATRC | MDLN |
|---|---|---|
| Market cap | $1.74 B | $49.12 B |
| US-listed rank | #2258 | #330 |
| Revenue (latest FY) | $534.53M | $28.43B |
| Net income (latest FY) | -$11.45M | $1.16T |
| Net margin | -2.1% | 4069.4% |
| P/E (trailing FY) | - | 0.0x |
| SEC filings | 1,528 | 103 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Medline Inc. is 28.3x more valuable than AtriCure, Inc. by market capitalization ($49.12 B vs $1.74 B).
In their latest fiscal years, AtriCure, Inc. reported $534.53M in revenue while Medline Inc. reported $28.43B.
Full pages: AtriCure, Inc. and Medline Inc., or browse the full rankings.